Business Context and Reporting Period
This Form 8-K was filed by LeMaitre Vascular, Inc. on October 24, 2016. The report primarily addresses corporate governance changes effective October 24, 2016, and references the issuance of a press release on October 26, 2016, regarding financial results for the quarter ended September 30, 2016.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
- Board Resignation: Cornelia W. LeMaitre resigned from the Board of Directors effective October 24, 2016.
- Board Appointment: Joseph P. Pellegrino, Jr. was appointed as a Class III director effective October 24, 2016. He will serve until the 2018 annual stockholders meeting.
- Executive Roles: Mr. Pellegrino concurrently serves as the Company's Chief Financial Officer, Treasurer, and Secretary.
Guidance, Outlook, and Risks
The filing does not contain specific guidance, outlook, or risk commentary within the text provided. It notes that the financial results and operational details are furnished in the attached press release (Exhibit 99.1) and explicitly states that this information is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 26, 2016) for specific Q3 2016 financial results.
- Verify the background and qualifications of the newly appointed director, Joseph P. Pellegrino, Jr.
- Confirm the status of the Board composition following the resignation of Cornelia W. LeMaitre.